Left main coronary artery (LMCA) atherosclerosis bears extra importance because of the large territory of myocardium supplied by the vessel. By convention, significant LMCA stenosis is treated by coronary artery bypass graft (CABG) surgery, and this type of lesion has long been regarded as a contraindication for percutaneous coronary intervention (PCI). However, with the advancement in interventional tools, operators' expertise, pharmaceuticals and supportive measures, outlook regarding left main PCI is changing. Recent clinical trials tell about the feasibility of LMCA PCI. The three cases of significant left main lesion presented here, were treated successfully by percutaneous transluminal coronary angioplasty (PTCA) with stenting in National Institute of Cardiovascular Diseases (NICVD), Dhaka. In near future, PCI may be an equally effective alternative to surgical revascularization in judiciously selected cases of LMCA stenosis even in Bangladesh.
normal. His ECG was within normal limits. CK-MB and troponin I were also normal. Echocardiography showed normal left ventricular (LV) wall motion and function. He was diagnosed as a case of unstable angina and treated accordingly with antiplatelets, beta-blockers, nitrate, atorvastatin and low-molecular-weight heparin. Coronary angiography revealed about 60% stenosis in the distal part of LMCA, and 75% stenosis in the mid segment of right coronary artery (RCA). Subsequently, elective PTCA with stenting to LMCA and RCA lesion was done. Arrangements for emergency CABG surgery were ensured beforehand. The LMCA lesion was negotiated with floppy PTCA guidewire, and a 3.0x9 mm cobultchromium stent was deployed at the lesion at 14 atm pressure. Another 2.75x10 mm cobalt-chromium stent was deployed across the RCA lesion at 8 atm pressure, preceded by dilatation with a 2.5x10 mm balloon at 8 atm. TIMI III flow was established (Fig. 2) . Post-procedural period was uneventful.
Case 3:
Mr. BK, a 55-year-old hypertensive, non-diabetic exsmoker, with no family history of coronary artery disease, presented to NICVD with history of acute inferior myocardial infarction 2 months back. His ECG showed pathological Q and inverted T waves in lead II, III and aVF. Echocardiography revealed inferior LV wall hypokinesia, with LVEF 50%. CAG done elsewhere, revealed 75-80% stenosis in LMCA, and 70-75% stenosis in the distal segment of RCA. Subsequently, elective PTCA with stenting to LMCA and RCA lesions was done ensuring arrangements for emergency CABG surgery. The LMCA lesion was negotiated with floppy PTCA guidewire, and a 3.5x10 mm drug-eluting stent was deployed at the lesion at 18 atm pressure. Another 2.5x22 mm cobalt-chromium stent was deployed across the RCA lesion at 16 atm pressure. TIMI III flow was established (Fig. 3) . Post-procedural period was uneventful. 
Discussion: Introduction and Epidemiology
The left main coronary artery atherosclerosis is a condition that merits special attention, because occlusion of LMCA is potentially fatal due to the large myocardial territory affected. 1 The prevalence of LMCA stenosis in patients undergoing CAG ranges from 2.5 to 10%, usually associated with lesions in other coronary branches. 2, 3 Isolated LMCA disease is very rare, only 0.07-0.15% in CAG patients. [4] [5] [6] Patients with significant LMCA stenosis who are on medical treatment, have a poor prognosis; three-year survival rate ranges from 60-82% 7, 8 , and 15-year survival rate was 27% 9 .
Peculiarity of LMCA Stenosis
The diameter of normal human LM coronary artery is 4.5± 0.5 mm in men and 3.9± 0.4 mm in women. 10 The LMCA directly originates from the ascending aorta, so all diseases of aorta affect the LM trunk. The LM trunk lacks adventitia and has greater amount of smooth muscle and elastic tissue which is probably responsible for the excellent 'acute success' of balloon dilatation but more chance of early and late recoil. 11 Because of larger diameter, percutaneous coronary intervention (PCI) seems to be a suitable procedure for treating LMCA lesions. 1 However, in case of restenosis, recurrence of angina is often accompanied by risk of developing acute left ventricular failure and sudden death. 1
Treatment Options for LMCA Stenosis
Coronary artery bypass graft is still regarded as the treatment of choice for significant LMCA stenosis. PCI is conventionally a class III recommendation for the same purpose as per the guidelines published by the American Heart Association/ American College of Cardiology. 12 However, with the introduction of coronary stents, several reports have demonstrated the feasibility of unprotected LMCA stenosis treatment by PCI. 13 Subsequently, drugeluting stents (DESs) in conjunction with advances in periprocedural and postprocedural adjunctive pharmacotherapies, have improved the outcomes of PCI in LMCA lesion. 14, 15 The Problems of PCI in LMCA Stenosis Gruntzig et al did the percutaneous transluminal coronary angioplasty (PTCA) of the unprotected LMCA stenosis for the first time, and reported that such procedures were quite difficult to perform and that early mortality was too high to be accepted as a standard treatment. 16 Subsequent reports of PTCA to LMCA were also disappointing. [17] [18] [19] [20] [21] LMCA stenosis was considered as a contraindication to PTCA in the consensus published by the Heart, Lung 
PCI versus CABG in LMCA Stenosis
Elective PCI in unprotected LMCA stenosis that can be treated by CABG, is a contraindication as per the current guidelines. 28 In-stent restenosis after BMS implantation is the most important reason for bypass surgery being the first choice of treatment. 29 However, this recommendation is based on the clinical trials that are more than 20 years old, so the results of these trials may not be optimally applicable to current practice. 30 On the other hand, recent observational studies and randomized trials comparing PTCA with stenting to CABG in the management of LMCA lesion are more encouraging. 24,27,31-38 Lee et al. 26 and Chieffo et al. 31 found better short-term outcomes in terms of death, myocardial infarction (MI) and target-vessel revascularization in PTCA with DES group. Death and MI after 6-12 months' observation were also less in DES implantation group, whereas restenosis rates were higher than that in CABG group. Palmerini et al found almost comparable results but MI and 14-month revascularization were less common in CABG group. 24 In a more recent study involving a cohort of patients with unprotected left main coronary artery disease, Seung et al 32 found no significant difference in rates of death or of the composite end point of death, Q-wave myocardial infarction, or stroke between patients receiving stents and those undergoing CABG, but stenting was associated with higher rates of target-vessel revascularization than was CABG. 
Drug-eluting Stent versus Bare-metal Stent in LMCA Stenosis
Angiographic and procedural successes do not differ significantly between DES and BMS in case of LMCA PCI. DES has been associated with reduced incidence of in-stent restenosis 40 at the cost of increased risk of late stent thrombosis. DES use in unprotected LMCA revascularization represents a narrow margin between the need for a potent antirestenotic effect balanced by the risk of stent thrombosis related to delayed healing. 41 Onuma et al. 42 compared the long-term clinical outcomes in unprotected LMCA PCI using DES (n=148) with those using BMS (n=79). The 4-year cumulative incidence of allcause death, any myocardial infarction, any revascularization, and patient-oriented composite were 35.6%, 3.8%, 25.2%, and 54.4%, respectively. Over 2 years of follow-up, the DES cohort had significantly higher patient-oriented composite end point in comparison to the BMS cohort (26% vs. 8%, p=0.02). However, recent multicenter registries evaluating the occurrence of late and very late stent thrombosis have shown the incidence of stent thrombosis to be 0.5 to 1.7%, which is a relatively uncommon phenomenon. 43, 44 In a large population of patients with lesions located at the ostium or the shaft of the left main in a real-world setting, DES were associated with favourable clinical outcomes when compared with BMS, although there was no evidence of a significant reduction in TLR with DES vs. BMS. 45 In a recently published meta-analysis DES has been found to be associated with favorable outcomes for mortality, myocardial infarction, target-vessel/lesion revascularization, and MACE as compared to BMS in unprotected LMCA PCI. 46
Conclusion:
The exact incidence and prevalence of LMCA stenosis in Bangladesh are unknown. In this country, a good number of PCIs is being performed round the year in Government and private levels. Like elsewhere, LMCA lesions are treated mainly by CABG surgery. However, operator expertise, pharmacotherapeutics and auxiliary supports are developing in this country day by day. The three cases of LMCA stenosis treated by PTCA with stenting presented, advocates the feasibility of complex coronary intervention here. PTCA with stenting specially using DES will hopefully become a viable alternative to CABG in carefully selected patients with left main disease.
